7272:TSEYamaha Motor Co., Ltd. Analysis
Data as of 2026-07-10 - not real-time
¥1,239.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Yamaha Motor (7272.T) trades at a trailing P/E of roughly 7.7× and a forward P/E under 7×, placing it well below the sector average and suggesting the stock is undervalued relative to earnings. The company delivers a solid dividend yield of about 4 % with a modest payout ratio of 22 %, indicating that the dividend is sustainable given the strong operating cash flow of over ¥190 bn. Revenue is expanding at a healthy 16 % year‑over‑year, driven by both its traditional motorcycle and marine businesses and a new push into laboratory automation, highlighted by the recent partnership with Nikon for the CELL HANDLER 2 system. Despite a high debt‑to‑equity ratio near 100 %, the balance sheet is cushioned by ¥437 bn of cash and a manageable free‑cash‑flow stream.
Technically, the price sits above its 20‑day and 50‑day SMAs and is comfortably above the 200‑day SMA, confirming a bullish trend. RSI hovers around the neutral 50‑point mark, while the MACD histogram has turned slightly negative, suggesting a short‑term caution but not a reversal. Volume has been tapering and 30‑day volatility is around 25 %, implying moderate price swings. Recent market sentiment is exuberant (Fear‑Greed Index in “Extreme Greed”) and analysts project a modest upside of roughly 3 % with a median target near ¥1,275. Together, these fundamentals and technical cues support a hold stance in the near term, a buy outlook over the medium horizon, and a cautious hold for the long run.
Technically, the price sits above its 20‑day and 50‑day SMAs and is comfortably above the 200‑day SMA, confirming a bullish trend. RSI hovers around the neutral 50‑point mark, while the MACD histogram has turned slightly negative, suggesting a short‑term caution but not a reversal. Volume has been tapering and 30‑day volatility is around 25 %, implying moderate price swings. Recent market sentiment is exuberant (Fear‑Greed Index in “Extreme Greed”) and analysts project a modest upside of roughly 3 % with a median target near ¥1,275. Together, these fundamentals and technical cues support a hold stance in the near term, a buy outlook over the medium horizon, and a cautious hold for the long run.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above key moving averages confirming bullish trend
- MACD histogram negative indicating short‑term caution
- Attractive dividend yield with low payout ratio
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth and entry into biotech automation
- Low valuation multiples (P/E, P/B, P/S) relative to peers
- Sustainable dividend and solid operating cash flow
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High leverage offset by sizable cash reserves
- Cyclical exposure of consumer‑cyclical auto segment
- Stable but modest profitability (ROE, ROA) and modest free cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth16.60%
Profit Margin1.01%
P/E Ratio7.7
ROE3.84%
ROA2.70%
Debt/Equity98.20
P/B Ratio1.0
Op. Cash Flow¥192.3B
Free Cash Flow¥18.5B
Technical Analysis
TrendBullish
RSI50.7
Support¥1,206.50
Resistance¥1,287.00
MA 20¥1,237.90
MA 50¥1,221.93
MA 200¥1,166.35
MACDBearish
VolumeDecreasing
Fear & Greed Index93.14
Valuation
Target Price¥1,276.00
Upside/Downside2.99%
GradeUndervalued
TypeBlend
Dividend Yield4.06%
Risk Assessment
Beta-0.02
Volatility25.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.